Caligan Partners LP

Q2 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    17

  • Value ($000)

    $520,168

  • Date Filed
    08/14/2025
  • Form type
    13F-HR
  • CIK
    0001727492
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
VRNA
VRNA

VERONA PHARMA PLC

SPONSORED ADS
925050106
$135.90M
26 %

1,436,878

LQDA
LQDA

LIQUIDIA CORPORATION

COM NEW
53635D202
$101.16M
19 %

8,118,892

EX9
EX9

EXELIXIS INC

COM
30161Q104
$67.25M
13 %

1,525,730

AGIO
AGIO

AGIOS PHARMACEUTICALS INC

COM
00847X104
$35.63M
7 %

1,071,258

---

MERUS N V

COM
N5749R100
$34.56M
7 %

656,999

EOLS
EOLS

EVOLUS INC

COM
30052C107
$30.78M
6 %

3,341,970

MLYS
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$27.29M
5 %

2,017,352

RVMD
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$23.43M
5 %

636,835

ANIK
ANIK

ANIKA THERAPEUTICS INC

COM
035255108
$15.18M
3 %

1,435,130

---

ABIVAX SA

SPONSORED ADS
00370M103
$12.81M
3 %

1,674,400

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 17